COSENTYX® Connect PsA Patient Support - COSENTYX (secukinumab)
2 Ways to Start

*Limitations apply. For those commercially insured and 18 years or older. Up to a $16,000 annual cap. Patient will be responsible for any co-pay once limit is reached in a calendar year. This offer is not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash-paying patients. Novartis reserves the right to rescind, revoke, or amend this program without notice. Enrollment expires 12/31/17. Covered Until You’re Covered Program: Eligible patients must have commercial insurance, a completed Service Request Form for COSENTYX and be experiencing a delay in obtaining coverage. Program provides initial 5 weekly doses (if prescribed) and monthly doses for free to patients for two years or until they receive insurance coverage approval. Enrolled patients awaiting coverage for COSENTYX after two years may be eligible for a Limited Program extension subject to approval by Novartis Pharmaceuticals Corporation. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, Tricare or any other federal or state program. No purchase necessary. Participation is not a guarantee of insurance coverage. Once coverage is approved, patients will no longer be eligible. Limitations may apply. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke or amend this Program without notice. Enrollment expires 12/31/17.

COSENTYX Connect Program Cosentyx Patient Support

*Limitations apply. For those commercially insured and 18 years or older. Up to a $16,000 annual cap. Patient will be responsible for any co-pay once limit is reached in a calendar year. This offer is not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash-paying patients. Novartis reserves the right to rescind, revoke, or amend this program without notice. Enrollment expires 12/31/17.

Covered Until You’re Covered Program: Eligible patients must have commercial insurance, a completed Service Request Form for COSENTYX and be experiencing a delay in obtaining coverage. Program provides initial 5 weekly doses (if prescribed) and monthly doses for free to patients for two years or until they receive insurance coverage approval. Enrolled patients awaiting coverage for COSENTYX after two years may be eligible for a Limited Program extension subject to approval by Novartis Pharmaceuticals Corporation. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, Tricare or any other federal or state program. No purchase necessary. Participation is not a guarantee of insurance coverage. Once coverage is approved, patients will no longer be eligible. Limitations may apply. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke or amend this Program without notice. Enrollment expires 12/31/17.